- NDA assigned a Target Action Date of February 25, 2026 - ...

In a clinical trial, a few people who took small doses of CBD saw their liver enzyme levels rise to more than three times ...

Nonclinical findings provide evidence of the mechanism of action of nomlabofusp and support the potential use of skin FXN concentrations as a novel surrogate endpoint for Larimar’s planned BLA ...